News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Grelan Pharmaceutical, Teijin Pharma To Jointly Market Lipid-lowering Agent In Japan



10/19/2005 5:11:05 PM

Grelan Pharmaceutical announced on April 26 that it has concluded a sales agreement with Teijin Pharma (TSE: 3401) for "Fenofibrate," a lipid-lowering agent manufactured by French Fournier Pharma. Under this agreement, Grelan and Teijin will jointly promote and distribute a pulverized type (fine powder) of "Fenofibrate."

Read at JCN Newswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES